In a regulatory filing, Cardinal Health (CAH) disclosed that its CEO Jason Hollar sold 107.7K shares of common stock on August 19th in a total transaction size of $16.04M.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health Secures $1 Billion in Notes Sale
- Cardinal Health price target raised to $203 from $197 at Baird
- Cardinal Health price target raised to $185 from $183 at Wells Fargo
- Cardinal Health’s Growth Potential: Buy Rating Reaffirmed Amid Strong Pharma Performance and Strategic Focus
- Cardinal Health Reports Strong Q4 and FY 2025 Results
